Action BDX * BECTON, DICKINSON AND COMPANY
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Becton, Dickinson and Company Mexican S.E.

Actions

BDX *

US0758871091

Cours en clôture Mexican S.E.
Autres places de cotation
 00:00:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
4 183 MXN +0,85 % Graphique intraday de Becton, Dickinson and Company -.--% +2,49 %
10/07 La FDA américaine signale une pénurie de tubes de test sanguin de Becton Dickinson RE
10/07 Becton, Dickinson déclare avoir dépassé ses objectifs de réduction des émissions pour 2023 MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Becton Dickinson and : Material Agreement Form 8 K
BD Statement on Supplier Issue Impacting BD BACTEC Blood Culture Vials
Health Care Up in Anticipation of Deal Activity -- Health Care Roundup
FDA Reports Supply Interruptions for Becton Dickinson BD BACTEC Culture Media Bottles
US FDA flags shortage of Becton Dickinson's blood test tubes
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
Becton, Dickinson Says it Exceeded 2023 Emissions Reduction Targets
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
BD to Announce Financial Results for its Third Quarter of Fiscal 2024
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
Becton Dickinson and : BD Issues Annual Product Security Report, Highlighting Transparency and Collaboration
Sector Update: Health Care Stocks Steady Premarket Monday
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BDX
  4. Action BDX *
  5. Actualités Becton, Dickinson and Company
  6. Autres langues